pAAV-GFAP-mKate2.5f Citations (3)
Originally described in: Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems.Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, Sanchez-Guardado L, Lois C, Mazmanian SK, Deverman BE, Gradinaru V Nat Neurosci. 2017 Aug;20(8):1172-1179. doi: 10.1038/nn.4593. Epub 2017 Jun 26. PubMed Journal
Articles Citing pAAV-GFAP-mKate2.5f
| Articles |
|---|
| Astroglial FMRP deficiency cell-autonomously up-regulates miR-128 and disrupts developmental astroglial mGluR5 signaling. Men Y, Ye L, Risgaard RD, Promes V, Zhao X, Paukert M, Yang Y. Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):25092-25103. doi: 10.1073/pnas.2014080117. Epub 2020 Sep 21. PubMed |
| Noradrenergic terminal short-term potentiation enables modality-selective integration of sensory input and vigilance state. Gray SR, Ye L, Ye JY, Paukert M. Sci Adv. 2021 Dec 17;7(51):eabk1378. doi: 10.1126/sciadv.abk1378. Epub 2021 Dec 17. PubMed |
Genetically encoded phosphatidylserine biosensor for in vitro, ex vivo and in vivo labelling.
Dirvelyte E, Bujanauskiene D, Jankaityte E, Daugelaviciene N, Kisieliute U, Nagula I, Budvytyte R, Neniskyte U.
Cell Mol Biol Lett. 2023 Jul 27;28(1):59. doi: 10.1186/s11658-023-00472-7.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.